High fructose corn syrup linked to cardiovascular disease in children, teens

Adolescents who consume foods and beverages containing high fructose corn syrup already have, present in their blood, evidence of risk factors for cardiovascular disease and diabetes according to a recent study. The results of the new study, to be published in February…

Vitamin D deficiency linked with airway changes in children with severe asthma

Children with severe therapy-resistant asthma (STRA) may have poorer lung function and worse symptoms compared to children with moderate asthma, due to lower levels of vitamin D in their blood, according to researchers. Lower levels of vitamin D may cause structural changes in the airway muscles of children with STRA, making breathing more difficult. The study provides important new evidence for possible treatments for the condition.

Insufficient vitamin D levels in chronic lymphocytic leukemia patients linked to cancer progression and death

Researchers have found a significant difference in cancer progression and death in chronic lymphocytic leukemia patients who had sufficient vitamin D levels in their blood compared to those who didn’t.

Lowering homocysteine levels with folic acid and vitamin B12 does not appear to reduce risk of heart attack, stroke, study finds

Patients who had experienced a heart attack and lowered their blood homocysteine levels with folic acid and vitamin B12 supplementation did not have an associated lower risk of heart attack, coronary death or stroke, according to a new study. However, the researchers did find that folic acid supplementation did not increase the risk of cancer, which has been speculated.

Blood Test Identifies Women At Risk From Alzheimer’s

Middle-aged women with high levels of a specific amino acid in their blood are twice as likely to suffer from Alzheimer’s many years later, reveals new research from Sweden. This discovery this could lead to a new and simple way of determining who is at risk long before there are any signs of the illness.

Investment In Parkinson’s Disease Data Bank Yields Potential Therapy

Individuals with Parkinson’s disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health. A clinical trial is under way to examine the safety and potential benefits of supplemental urate elevation for recently diagnosed Parkinson’s patients who have low urate levels.